グローバル医薬品の不純物検査サービス市場規模、主要企業シェア、ランキング分析レポート【2026年版】
Pharmaceutical lmpurity Testing Service - Global Top Players Market Share and Ranking 2026

- レポートID:191427
- 発表時期:2026-02-06
- レポート形式:PDF
- 産業カテゴリー:医療機器と消耗材
- レポート言語:英語、日本語
- ページ数:119
- 発行会社(調査会社):YHResearch
言語とエディションの価格
- 英語版
- 日本語版
- 英語と日本語版
個人版詳細
マルチユーザー版詳細
企業版詳細
- 英語版
- 日本語版
- 英語と日本語版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=162.40円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
レポートの概要
本報告書は、世界の医薬品の不純物検査サービス市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から医薬品の不純物検査サービス市場を分析し、需要構造と成長特性を明確化します。
医薬品の不純物検査サービス市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、医薬品の不純物検査サービスに関する的確な意思決定を行うための実践的なインサイトを提供します。
主要医薬品の不純物検査サービス市場の統計
2025年世界市場規模:百万米ドル
2026年世界市場規模:百万米ドル
2032年予測市場規模:百万米ドル
2026–2032年予測期間CAGR:
本レポートは医薬品の不純物検査サービス市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。
【市場セグメンテーション】
主要企業・競争環境
医薬品の不純物検査サービス市場の主要企業には以下が含まれます:
Charles River
Intertek
Profacgen
Eurofins Analytical Science Laboratories, Inc. (E-ASL)
SGS
Element
Drug Development Solutions Limited
Leeder Analytical
Thermo Fisher Scientific
Selvita
Impact Analytical
EKG Life Science Solutions, LLC (EKG Labs)
Merck
SwRI
Emery Pharma
Cotecna
Roche
製品別
Destructive Testing
Non-destructive Testing
アプリケーション別
Biopharma
New Drug Research & Development
Gene Therapy
Others
レポート対象地域
北米:アメリカ、カナダ、その他
アジア太平洋:中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ:メキシコ、ブラジル、その他
中東・アフリカ:トルコ、サウジアラビア、UAE、その他
レポート構成(章別概要)
第1章|市場概要と成長展望
医薬品の不純物検査サービス市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章|主要企業の競争分析
医薬品の不純物検査サービス市場における主要プレイヤー(トップ5社・トップ10社)を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章|製品カテゴリ別市場動向
製品タイプ別に医薬品の不純物検査サービス市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章|用途別市場動向
用途別に医薬品の不純物検査サービス市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章|地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、医薬品の不純物検査サービス市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章|国別市場動向
主要国・地域ごとに、医薬品の不純物検査サービス市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章|主要企業プロファイル
医薬品の不純物検査サービス市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章|バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章|調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章|付録(調査手法・データソース)
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します
本レポートの要点と洞察
医薬品の不純物検査サービス市場の全体像と成長見通し
医薬品の不純物検査サービス市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が医薬品の不純物検査サービス市場に与える影響を分析いたします
市場環境の構成要素とマクロトレンド
医薬品の不純物検査サービス産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
競争構造と主要企業の動向分析
医薬品の不純物検査サービス市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から医薬品の不純物検査サービス市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
成長要因・課題・リスクの分析
医薬品の不純物検査サービス市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
将来トレンドと市場展望
医薬品の不純物検査サービス市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
Description
According to YH Research, the global market for Pharmaceutical lmpurity Testing Service should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of %for the period of 2026-2032.
Pharmaceutical Impurity Testing Service refers to the analytical testing of pharmaceutical compounds to identify and quantify impurities or degradation products that may be present in drug substances or drug products. These impurities can arise from different sources such as drug manufacturing processes, storage conditions, or interactions with other chemical moieties. It is crucial to detect and monitor these impurities to ensure the safety, efficacy, and quality of pharmaceutical products, as some of them can cause adverse effects on human health. The testing process usually involves sophisticated analytical techniques such as chromatography, mass spectrometry, or spectroscopy, and must comply with regulatory requirements set by health authorities such as the FDA or EMA.
By country, Japan accounted for percent of the global market last year and Japan’s market share increased from percent to percent. Japan Pharmaceutical lmpurity Testing Service market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032. The United States Pharmaceutical lmpurity Testing Service market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032.
By segment, Biopharma grew percent to account for percent of the total market sales, and New Drug Research & Development grew percent.
This report studies and analyses global Pharmaceutical lmpurity Testing Service status and future trends, to help determine the Pharmaceutical lmpurity Testing Service market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Pharmaceutical lmpurity Testing Service, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Pharmaceutical lmpurity Testing Service market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Pharmaceutical lmpurity Testing Service by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Pharmaceutical lmpurity Testing Service by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Pharmaceutical lmpurity Testing Service key consuming regions, consumption value and demand structure
(5) Pharmaceutical lmpurity Testing Service industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Charles River
Intertek
Profacgen
Eurofins Analytical Science Laboratories, Inc. (E-ASL)
SGS
Element
Drug Development Solutions Limited
Leeder Analytical
Thermo Fisher Scientific
Selvita
Impact Analytical
EKG Life Science Solutions, LLC (EKG Labs)
Merck
SwRI
Emery Pharma
Cotecna
Roche
Market segment by Type, covers
Destructive Testing
Non-destructive Testing
Market segment by Application, can be divided into
Biopharma
New Drug Research & Development
Gene Therapy
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Pharmaceutical lmpurity Testing Service product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Pharmaceutical lmpurity Testing Service market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Pharmaceutical lmpurity Testing Service market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Pharmaceutical lmpurity Testing Service industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions
Table of Contents
1 Market Overview
1.1 Pharmaceutical lmpurity Testing Service Definition
1.2 Global Pharmaceutical lmpurity Testing Service Market Size and Forecast
1.3 Japan Pharmaceutical lmpurity Testing Service Market Size and Forecast
1.4 Share of Japan Pharmaceutical lmpurity Testing Service Market with Respect to the Global Market
1.5 Pharmaceutical lmpurity Testing Service Market Size: Japan VS Global Growth Rate, 2021-2032
1.6 Pharmaceutical lmpurity Testing Service Market Dynamics
1.6.1 Pharmaceutical lmpurity Testing Service Market Drivers
1.6.2 Pharmaceutical lmpurity Testing Service Market Restraints
1.6.3 Pharmaceutical lmpurity Testing Service Industry Trends
1.6.4 Pharmaceutical lmpurity Testing Service Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Pharmaceutical lmpurity Testing Service, Global Market Share by Company, 2021-2026
2.2 Global Pharmaceutical lmpurity Testing Service Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Pharmaceutical lmpurity Testing Service Concentration Ratio
2.4 Global Pharmaceutical lmpurity Testing Service Mergers & Acquisitions, Expansion Plans
2.5 Global Pharmaceutical lmpurity Testing Service Major Companies Product Type
2.6 Head Office and Area Served of Key Players
3 Japan Leading Players, Market Share and Ranking
3.1 By Revenue of Pharmaceutical lmpurity Testing Service, Japan Market Share by Company, 2021-2026
3.2 Japan Pharmaceutical lmpurity Testing Service Pharmaceutical lmpurity Testing Service Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Pharmaceutical lmpurity Testing Service Industry Chain
4.2 Pharmaceutical lmpurity Testing Service Upstream Analysis
4.2.1 Pharmaceutical lmpurity Testing Service Core Raw Materials
4.2.2 Main Manufacturers of Pharmaceutical lmpurity Testing Service Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Pharmaceutical lmpurity Testing Service Production Mode
4.6 Pharmaceutical lmpurity Testing Service Procurement Model
4.7 Pharmaceutical lmpurity Testing Service Industry Sales Model and Sales Channels
4.7.1 Pharmaceutical lmpurity Testing Service Sales Model
4.7.2 Pharmaceutical lmpurity Testing Service Typical Distributors
5 Sights by Type
5.1 Pharmaceutical lmpurity Testing Service Classification by Type
5.1.1 Destructive Testing
5.1.2 Non-destructive Testing
5.2 by Type, Global Pharmaceutical lmpurity Testing Service Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.3 by Type, Global Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032
6 Sights by Application
6.1 Pharmaceutical lmpurity Testing Service Segment by Application
6.1.1 Biopharma
6.1.2 New Drug Research & Development
6.1.3 Gene Therapy
6.1.4 Others
6.2 by Application, Global Pharmaceutical lmpurity Testing Service Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Application, Global Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032
7 Sales Sights by Region
7.1 By Region, Global Pharmaceutical lmpurity Testing Service Consumption Value, 2021 VS 2025 VS 2032
7.2 By Region, Global Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032
7.3 North America
7.3.1 North America Pharmaceutical lmpurity Testing Service Market Size & Forecasts, 2021-2032
7.3.2 By Country, North America Pharmaceutical lmpurity Testing Service Market Size Market Share
7.4 Europe
7.4.1 Europe Pharmaceutical lmpurity Testing Service Market Size & Forecasts, 2021-2032
7.4.2 By Country, Europe Pharmaceutical lmpurity Testing Service Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Pharmaceutical lmpurity Testing Service Market Size & Forecasts, 2021-2032
7.5.2 By Country/Region, Asia Pacific Pharmaceutical lmpurity Testing Service Market Size Market Share
7.6 South America
7.6.1 South AmericaPharmaceutical lmpurity Testing Service Market Size & Forecasts, 2021-2032
7.6.2 By Country, South America Pharmaceutical lmpurity Testing Service Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Pharmaceutical lmpurity Testing Service Market Size & CAGR, 2021 VS 2025 VS 2032
8.2 By Country, Global Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032
8.3 United States
8.3.1 United States Pharmaceutical lmpurity Testing Service Market Size, 2021-2032
8.3.2 by Type, United States Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.3.3 by Application, United States Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.4 Europe
8.4.1 Europe Pharmaceutical lmpurity Testing Service Market Size, 2021-2032
8.4.2 by Type, Europe Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.4.3 by Application, Europe Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.5 China
8.5.1 China Pharmaceutical lmpurity Testing Service Market Size, 2021-2032
8.5.2 by Type, China Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.5.3 by Application, China Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.6 Japan
8.6.1 Japan Pharmaceutical lmpurity Testing Service Market Size, 2021-2032
8.6.2 by Type, Japan Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.6.3 by Application, Japan Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.7 South Korea
8.7.1 South Korea Pharmaceutical lmpurity Testing Service Market Size, 2021-2032
8.7.2 by Type, South Korea Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.7.3 by Application, South Korea Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.8 Southeast Asia
8.8.1 Southeast Asia Pharmaceutical lmpurity Testing Service Market Size, 2021-2032
8.8.2 by Type, Southeast Asia Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.8.3 by Application, Southeast Asia Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.9 India
8.9.1 India Pharmaceutical lmpurity Testing Service Market Size, 2021-2032
8.9.2 by Type, India Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.9.3 by Application, India Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.10 Middle East & Africa
8.10.1 Middle East & Africa Pharmaceutical lmpurity Testing Service Market Size, 2021-2032
8.10.2 by Type, Middle East & Africa Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
8.10.3 by Application, Middle East & Africa Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032
9 Company Profile
9.1 Charles River
9.1.1 Charles River Company Information, Head Office, Market Area, and Industry Position
9.1.2 Charles River Company Profile and Main Business
9.1.3 Charles River Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.1.4 Charles River Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.1.5 Charles River Recent Developments
9.2 Intertek
9.2.1 Intertek Company Information, Head Office, Market Area, and Industry Position
9.2.2 Intertek Company Profile and Main Business
9.2.3 Intertek Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.2.4 Intertek Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.2.5 Intertek Recent Developments
9.3 Profacgen
9.3.1 Profacgen Company Information, Head Office, Market Area, and Industry Position
9.3.2 Profacgen Company Profile and Main Business
9.3.3 Profacgen Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.3.4 Profacgen Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.3.5 Profacgen Recent Developments
9.4 Eurofins Analytical Science Laboratories, Inc. (E-ASL)
9.4.1 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Company Information, Head Office, Market Area, and Industry Position
9.4.2 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Company Profile and Main Business
9.4.3 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.4.4 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.4.5 Eurofins Analytical Science Laboratories, Inc. (E-ASL) Recent Developments
9.5 SGS
9.5.1 SGS Company Information, Head Office, Market Area, and Industry Position
9.5.2 SGS Company Profile and Main Business
9.5.3 SGS Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.5.4 SGS Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.5.5 SGS Recent Developments
9.6 Element
9.6.1 Element Company Information, Head Office, Market Area, and Industry Position
9.6.2 Element Company Profile and Main Business
9.6.3 Element Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.6.4 Element Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.6.5 Element Recent Developments
9.7 Drug Development Solutions Limited
9.7.1 Drug Development Solutions Limited Company Information, Head Office, Market Area, and Industry Position
9.7.2 Drug Development Solutions Limited Company Profile and Main Business
9.7.3 Drug Development Solutions Limited Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.7.4 Drug Development Solutions Limited Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.7.5 Drug Development Solutions Limited Recent Developments
9.8 Leeder Analytical
9.8.1 Leeder Analytical Company Information, Head Office, Market Area, and Industry Position
9.8.2 Leeder Analytical Company Profile and Main Business
9.8.3 Leeder Analytical Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.8.4 Leeder Analytical Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.8.5 Leeder Analytical Recent Developments
9.9 Thermo Fisher Scientific
9.9.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
9.9.2 Thermo Fisher Scientific Company Profile and Main Business
9.9.3 Thermo Fisher Scientific Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.9.4 Thermo Fisher Scientific Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.9.5 Thermo Fisher Scientific Recent Developments
9.10 Selvita
9.10.1 Selvita Company Information, Head Office, Market Area, and Industry Position
9.10.2 Selvita Company Profile and Main Business
9.10.3 Selvita Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.10.4 Selvita Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.10.5 Selvita Recent Developments
9.11 Impact Analytical
9.11.1 Impact Analytical Company Information, Head Office, Market Area, and Industry Position
9.11.2 Impact Analytical Company Profile and Main Business
9.11.3 Impact Analytical Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.11.4 Impact Analytical Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.11.5 Impact Analytical Recent Developments
9.12 EKG Life Science Solutions, LLC (EKG Labs)
9.12.1 EKG Life Science Solutions, LLC (EKG Labs) Company Information, Head Office, Market Area, and Industry Position
9.12.2 EKG Life Science Solutions, LLC (EKG Labs) Company Profile and Main Business
9.12.3 EKG Life Science Solutions, LLC (EKG Labs) Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.12.4 EKG Life Science Solutions, LLC (EKG Labs) Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.12.5 EKG Life Science Solutions, LLC (EKG Labs) Recent Developments
9.13 Merck
9.13.1 Merck Company Information, Head Office, Market Area, and Industry Position
9.13.2 Merck Company Profile and Main Business
9.13.3 Merck Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.13.4 Merck Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.13.5 Merck Recent Developments
9.14 SwRI
9.14.1 SwRI Company Information, Head Office, Market Area, and Industry Position
9.14.2 SwRI Company Profile and Main Business
9.14.3 SwRI Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.14.4 SwRI Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.14.5 SwRI Recent Developments
9.15 Emery Pharma
9.15.1 Emery Pharma Company Information, Head Office, Market Area, and Industry Position
9.15.2 Emery Pharma Company Profile and Main Business
9.15.3 Emery Pharma Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.15.4 Emery Pharma Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.15.5 Emery Pharma Recent Developments
9.16 Cotecna
9.16.1 Cotecna Company Information, Head Office, Market Area, and Industry Position
9.16.2 Cotecna Company Profile and Main Business
9.16.3 Cotecna Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.16.4 Cotecna Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.16.5 Cotecna Recent Developments
9.17 Roche
9.17.1 Roche Company Information, Head Office, Market Area, and Industry Position
9.17.2 Roche Company Profile and Main Business
9.17.3 Roche Pharmaceutical lmpurity Testing Service Models, Specifications, and Application
9.17.4 Roche Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, 2021-2026
9.17.5 Roche Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table of Figures
List of Tables Table 1. Pharmaceutical lmpurity Testing Service Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million Table 2. Pharmaceutical lmpurity Testing Service Market Restraints Table 3. Pharmaceutical lmpurity Testing Service Market Trends Table 4. Pharmaceutical lmpurity Testing Service Industry Policy Table 5. Global Pharmaceutical lmpurity Testing Service Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 6. Global Pharmaceutical lmpurity Testing Service Revenue Share by Company, 2021-2026, Ranked by Data of 2025 Table 7. Global Pharmaceutical lmpurity Testing Service Manufacturers Market Concentration Ratio (CR3 and HHI) Table 8. Global Pharmaceutical lmpurity Testing Service Mergers & Acquisitions, Expansion Plans Table 9. Global Pharmaceutical lmpurity Testing Service Major Companies Product Type Table 10. Head Office and Area Served of Key Players Table 11. Japan Pharmaceutical lmpurity Testing Service Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 12. Japan Pharmaceutical lmpurity Testing Service Revenue Market Share by Company, 2021-2026 Table 13. Global Key Players of Pharmaceutical lmpurity Testing Service Upstream (Raw Materials) Table 14. Global Pharmaceutical lmpurity Testing Service Typical Customers Table 15. Pharmaceutical lmpurity Testing Service Typical Distributors Table 16. by Type, Global Pharmaceutical lmpurity Testing Service Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 17. by Application, Global Pharmaceutical lmpurity Testing Service Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 18. By Region, Global Pharmaceutical lmpurity Testing Service Consumption Value, 2021 VS 2025 VS 2032, US$ Million Table 19. By Region, Global Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Table 20. By Country, Global Pharmaceutical lmpurity Testing Service Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 21. By Country, Global Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Table 22. By Country, Global Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2021-2032 Table 23. Charles River Company Information, Head Office, Market Area, and Industry Position Table 24. Charles River Company Profile and Main Business Table 25. Charles River Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 26. Charles River Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 27. Charles River Recent Developments Table 28. Intertek Company Information, Head Office, Market Area, and Industry Position Table 29. Intertek Company Profile and Main Business Table 30. Intertek Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 31. Intertek Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 32. Intertek Recent Developments Table 33. Profacgen Company Information, Head Office, Market Area, and Industry Position Table 34. Profacgen Company Profile and Main Business Table 35. Profacgen Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 36. Profacgen Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 37. Profacgen Recent Developments Table 38. Eurofins Analytical Science Laboratories, Inc. (E-ASL) Company Information, Head Office, Market Area, and Industry Position Table 39. Eurofins Analytical Science Laboratories, Inc. (E-ASL) Company Profile and Main Business Table 40. Eurofins Analytical Science Laboratories, Inc. (E-ASL) Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 41. Eurofins Analytical Science Laboratories, Inc. (E-ASL) Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 42. Eurofins Analytical Science Laboratories, Inc. (E-ASL) Recent Developments Table 43. SGS Company Information, Head Office, Market Area, and Industry Position Table 44. SGS Company Profile and Main Business Table 45. SGS Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 46. SGS Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 47. SGS Recent Developments Table 48. Element Company Information, Head Office, Market Area, and Industry Position Table 49. Element Company Profile and Main Business Table 50. Element Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 51. Element Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 52. Element Recent Developments Table 53. Drug Development Solutions Limited Company Information, Head Office, Market Area, and Industry Position Table 54. Drug Development Solutions Limited Company Profile and Main Business Table 55. Drug Development Solutions Limited Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 56. Drug Development Solutions Limited Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 57. Drug Development Solutions Limited Recent Developments Table 58. Leeder Analytical Company Information, Head Office, Market Area, and Industry Position Table 59. Leeder Analytical Company Profile and Main Business Table 60. Leeder Analytical Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 61. Leeder Analytical Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 62. Leeder Analytical Recent Developments Table 63. Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position Table 64. Thermo Fisher Scientific Company Profile and Main Business Table 65. Thermo Fisher Scientific Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 66. Thermo Fisher Scientific Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 67. Thermo Fisher Scientific Recent Developments Table 68. Selvita Company Information, Head Office, Market Area, and Industry Position Table 69. Selvita Company Profile and Main Business Table 70. Selvita Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 71. Selvita Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 72. Selvita Recent Developments Table 73. Impact Analytical Company Information, Head Office, Market Area, and Industry Position Table 74. Impact Analytical Company Profile and Main Business Table 75. Impact Analytical Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 76. Impact Analytical Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 77. Impact Analytical Recent Developments Table 78. EKG Life Science Solutions, LLC (EKG Labs) Company Information, Head Office, Market Area, and Industry Position Table 79. EKG Life Science Solutions, LLC (EKG Labs) Company Profile and Main Business Table 80. EKG Life Science Solutions, LLC (EKG Labs) Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 81. EKG Life Science Solutions, LLC (EKG Labs) Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 82. EKG Life Science Solutions, LLC (EKG Labs) Recent Developments Table 83. Merck Company Information, Head Office, Market Area, and Industry Position Table 84. Merck Company Profile and Main Business Table 85. Merck Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 86. Merck Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 87. Merck Recent Developments Table 88. SwRI Company Information, Head Office, Market Area, and Industry Position Table 89. SwRI Company Profile and Main Business Table 90. SwRI Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 91. SwRI Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 92. SwRI Recent Developments Table 93. Emery Pharma Company Information, Head Office, Market Area, and Industry Position Table 94. Emery Pharma Company Profile and Main Business Table 95. Emery Pharma Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 96. Emery Pharma Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 97. Emery Pharma Recent Developments Table 98. Cotecna Company Information, Head Office, Market Area, and Industry Position Table 99. Cotecna Company Profile and Main Business Table 100. Cotecna Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 101. Cotecna Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 102. Cotecna Recent Developments Table 103. Roche Company Information, Head Office, Market Area, and Industry Position Table 104. Roche Company Profile and Main Business Table 105. Roche Pharmaceutical lmpurity Testing Service Models, Specifications, and Application Table 106. Roche Pharmaceutical lmpurity Testing Service Revenue and Gross Margin, US$ Million, 2021-2026 Table 107. Roche Recent Developments List of Figures Figure 1. Pharmaceutical lmpurity Testing Service Picture Figure 2. Global Pharmaceutical lmpurity Testing Service Consumption Value, (US$ million) & (2021-2032) Figure 3. Japan Pharmaceutical lmpurity Testing Service Consumption Value, (US$ million) & (2021-2032) Figure 4. By Consumption Value, Japan Pharmaceutical lmpurity Testing Service Market Share of Global, 2021-2032 Figure 5. Global Pharmaceutical lmpurity Testing Service Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025 Figure 6. Japan Pharmaceutical lmpurity Testing Service Key Participants, Market Share, 2025 Figure 7. Pharmaceutical lmpurity Testing Service Industry Chain Figure 8. Pharmaceutical lmpurity Testing Service Procurement Model Figure 9. Pharmaceutical lmpurity Testing Service Sales Model Figure 10. Pharmaceutical lmpurity Testing Service Sales Channels, Direct Sales, and Distribution Figure 11. Destructive Testing Figure 12. Non-destructive Testing Figure 13. by Type, Global Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Figure 14. by Type, Global Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2021-2032 Figure 15. Biopharma Figure 16. New Drug Research & Development Figure 17. Gene Therapy Figure 18. Others Figure 19. by Application, Global Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Figure 20. by Application, Global Pharmaceutical lmpurity Testing Service Revenue Market Share, 2021-2032 Figure 21. By Region, Global Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2021-2032 Figure 22. North America Pharmaceutical lmpurity Testing Service Consumption Value & Forecasts, 2021-2032, US$ Million Figure 23. By Country, North America Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 Figure 24. Europe Pharmaceutical lmpurity Testing Service Consumption Value & Forecasts, 2021-2032, US$ Million Figure 25. By Country, Europe Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 Figure 26. Asia Pacific Pharmaceutical lmpurity Testing Service Consumption Value & Forecasts, 2021-2032, US$ Million Figure 27. By Country/Region, Asia Pacific Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 Figure 28. South America Pharmaceutical lmpurity Testing Service Consumption Value & Forecasts, 2021-2032, US$ Million Figure 29. By Country, South America Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 Figure 30. Middle East & Africa Pharmaceutical lmpurity Testing Service Consumption Value & Forecasts, 2021-2032, US$ Million Figure 31. United States Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Figure 32. by Type, United States Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 33. by Application, United States Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 34. Europe Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Figure 35. by Type, Europe Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 36. by Application, Europe Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 37. China Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Figure 38. by Type, China Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 39. by Application, China Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 40. Japan Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Figure 41. by Type, Japan Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 42. by Application, Japan Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 43. South Korea Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Figure 44. by Type, South Korea Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 45. by Application, South Korea Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 46. Southeast Asia Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Figure 47. by Type, Southeast Asia Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 48. by Application, Southeast Asia Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 49. India Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Figure 50. by Type, India Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 51. by Application, India Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 52. Middle East & Africa Pharmaceutical lmpurity Testing Service Consumption Value, 2021-2032, US$ Million Figure 53. by Type, Middle East & Africa Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 54. by Application, Middle East & Africa Pharmaceutical lmpurity Testing Service Consumption Value Market Share, 2025 VS 2032 Figure 55. Research Methodology Figure 56. Breakdown of Primary Interviews Figure 57. Bottom-up Approaches Figure 58. Top-down Approaches
お見積>
サンプルお申込み>
今すぐ購入>
PDFダウンロード>






